PMID- 31387822
OWN - NLM
STAT- MEDLINE
DCOM- 20201130
LR  - 20201130
IS  - 1874-1754 (Electronic)
IS  - 0167-5273 (Linking)
VI  - 300
DP  - 2020 Feb 1
TI  - Impact of telephone follow-up and 24/7 hotline on 30-day readmission rates 
      following aortic valve replacement -A randomized controlled trial.
PG  - 66-72
LID - S0167-5273(18)36036-4 [pii]
LID - 10.1016/j.ijcard.2019.07.087 [doi]
AB  - BACKGROUND: Thirty-day all-cause readmissions are high after aortic valve 
      replacement (AVR). We aimed to assess the effectiveness of a structured telephone 
      follow-up (TFU) and a 24/7 hotline on reducing 30-day all-cause readmission 
      (30-DACR) after AVR, on reducing symptoms of anxiety and depression and on 
      improving perceived health state. METHODS: A prospective randomized controlled 
      trial was conducted. Patients (n = 288) were randomly allocated to either 
      post-discharge usual care or to care that provided TFU and access to a 24/7 
      hotline after AVR. Ancillary endpoints were time-to-event (readmission), 
      proportion of avoidable versus unavoidable readmissions after AVR, and predictors 
      of 30-DACR after AVR. RESULTS: 30-DACR was 22.3%. The structured TFU and 24/7 
      hotline intervention failed to reduce 30-DACR rates after AVR (P = 0.274). 
      Symptoms of anxiety were significantly reduced 30 days after surgery (P = 0.031), 
      an effect that did not persist one year after surgery (P = 0.108). Most 
      readmissions occurred before 15 days post-discharge, and 75% of them were deemed 
      to be unavoidable. Pleural drainage before hospital discharge (P = 0.027) and 
      symptoms of anxiety before surgery (P = 0.003) were predictors of 30-DACR after 
      AVR. CONCLUSION: The TFU and 24/7 hotline had no effect on reducing 30-DACR after 
      AVR. However, we did measure reduced symptoms of anxiety the first month after 
      AVR. Anxiety reduction appeared to be an important target for intervention, 
      because we found it to be a risk factor for readmission. Future research should 
      focus on the effectiveness of interventions to prevent avoidable unplanned 
      readmissions. TRIAL REGISTRATION: ClinicalTrial.gov, NCT02522663.
CI  - Copyright (c) 2019 Elsevier B.V. All rights reserved.
FAU - Danielsen, Stein Ove
AU  - Danielsen SO
AD  - Center for Patient-centered Heart and Lung Research, Department of Cardiothoracic 
      Surgery, Division of Cardiovascular and Pulmonary Diseases, Oslo University 
      Hospital, Ulleval, Oslo, Norway; Institute of Clinical Medicine, Faculty of 
      Medicine, University of Oslo, Oslo, Norway; KU Leuven Department of Public Health 
      and Primary Care, KU Leuven-University of Leuven, Leuven, Belgium. Electronic 
      address: steinda@uio.no.
FAU - Moons, Philip
AU  - Moons P
AD  - KU Leuven Department of Public Health and Primary Care, KU Leuven-University of 
      Leuven, Leuven, Belgium; Institute of Health and Care Sciences, University of 
      Gothenburg, Gothenburg, Sweden; Department of Paediatrics and Child Health, 
      University of Cape Town, South Africa.
FAU - Sandvik, Leiv
AU  - Sandvik L
AD  - Oslo Centre of Biostatistics and Epidemiology, Oslo University Hospital, Oslo, 
      Norway.
FAU - Leegaard, Marit
AU  - Leegaard M
AD  - Department of Nursing and Health Promotion, Faculty of Health Sciences, Oslo 
      Metropolitan University, Oslo, Norway.
FAU - Solheim, Svein
AU  - Solheim S
AD  - Center for Clinical Heart Research, Department of Cardiology, Division of 
      Medicine, Oslo University Hospital, Ulleval, Oslo, Norway.
FAU - Tonnessen, Theis
AU  - Tonnessen T
AD  - Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, 
      Norway; Department of Cardiothoracic Surgery, Division of Cardiovascular and 
      Pulmonary Diseases, Oslo University Hospital, Ulleval, Oslo, Norway.
FAU - Lie, Irene
AU  - Lie I
AD  - Center for Patient-centered Heart and Lung Research, Department of Cardiothoracic 
      Surgery, Division of Cardiovascular and Pulmonary Diseases, Oslo University 
      Hospital, Ulleval, Oslo, Norway.
LA  - eng
SI  - ClinicalTrials.gov/NCT02522663
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20190730
PL  - Netherlands
TA  - Int J Cardiol
JT  - International journal of cardiology
JID - 8200291
SB  - IM
MH  - Aftercare
MH  - Aged
MH  - Anxiety/epidemiology/*psychology/*therapy
MH  - Female
MH  - Follow-Up Studies
MH  - Heart Valve Prosthesis Implantation/*psychology/*trends
MH  - Hotlines/methods/*trends
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Patient Discharge/trends
MH  - Patient Readmission/*trends
MH  - Prospective Studies
MH  - Telephone
OTO - NOTNLM
OT  - 30-day readmission
OT  - Aortic valve replacement
OT  - Aortic valve stenosis
OT  - Hotline
OT  - Telephone follow-up
EDAT- 2019/08/08 06:00
MHDA- 2020/12/01 06:00
CRDT- 2019/08/08 06:00
PHST- 2019/02/12 00:00 [received]
PHST- 2019/07/11 00:00 [revised]
PHST- 2019/07/29 00:00 [accepted]
PHST- 2019/08/08 06:00 [pubmed]
PHST- 2020/12/01 06:00 [medline]
PHST- 2019/08/08 06:00 [entrez]
AID - S0167-5273(18)36036-4 [pii]
AID - 10.1016/j.ijcard.2019.07.087 [doi]
PST - ppublish
SO  - Int J Cardiol. 2020 Feb 1;300:66-72. doi: 10.1016/j.ijcard.2019.07.087. Epub 2019 
      Jul 30.